Biotechnology
Compare Stocks
5 / 10Stock Comparison
BTX vs BLK vs STT vs BEN vs IVZ
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
Asset Management
BTX vs BLK vs STT vs BEN vs IVZ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Biotechnology | Asset Management | Asset Management | Asset Management | Asset Management |
| Market Cap | $945M | $165.65B | $41.99B | $15.86B | $11.92B |
| Revenue (TTM) | $41M | $20.41B | $21.97B | $8.77B | $6.38B |
| Net Income (TTM) | $36M | $6.10B | $2.98B | $812M | $-243M |
| Gross Margin | 100.0% | 49.4% | 58.5% | 80.3% | 43.2% |
| Operating Margin | 87.7% | 37.1% | 15.5% | 6.9% | -10.9% |
| Forward P/E | 47.6x | 20.1x | 12.0x | 11.2x | 10.4x |
| Total Debt | $0.00 | $14.22B | $36.79B | $13.30B | $10.12B |
| Cash & Equiv. | — | $12.76B | $116.10B | $3.57B | $1.98B |
BTX vs BLK vs STT vs BEN vs IVZ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| BlackRock Technolog… (BTX) | 100 | 39.9 | -60.1% |
| BlackRock, Inc. (BLK) | 100 | 141.6 | +41.6% |
| State Street Corpor… (STT) | 100 | 177.1 | +77.1% |
| Franklin Resources,… (BEN) | 100 | 103.1 | +3.1% |
| Invesco Ltd. (IVZ) | 100 | 106.4 | +6.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BTX vs BLK vs STT vs BEN vs IVZ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BTX has the current edge in this matchup, primarily because of its strength in quality and dividends.
- 87.7% margin vs IVZ's -4.4%
- 10.6% yield, 1-year raise streak, vs BLK's 1.9%
BLK is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 245.8% 10Y total return vs STT's 186.8%
- Lower volatility, beta 1.28, Low D/E 28.8%, current ratio 16.40x
- Beta 1.28, yield 1.9%, current ratio 16.40x
- 3.7% ROA vs IVZ's -0.9%, ROIC 9.9% vs -2.3%
STT is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 19.6%, EPS growth 47.1%
- PEG 1.36 vs BLK's 2.47
- NIM 0.8% vs BLK's 0.2%
- 19.6% NII/revenue growth vs BTX's -81.1%
BEN is the clearest fit if your priority is income & stability.
- Dividend streak 6 yrs, beta 1.31, yield 4.3%
IVZ ranks third and is worth considering specifically for value and momentum.
- Lower P/E (10.4x vs 11.2x)
- +93.1% vs BLK's +18.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.6% NII/revenue growth vs BTX's -81.1% | |
| Value | Lower P/E (10.4x vs 11.2x) | |
| Quality / Margins | 87.7% margin vs IVZ's -4.4% | |
| Stability / Safety | Beta 1.19 vs IVZ's 1.67 | |
| Dividends | 10.6% yield, 1-year raise streak, vs BLK's 1.9% | |
| Momentum (1Y) | +93.1% vs BLK's +18.3% | |
| Efficiency (ROA) | 3.7% ROA vs IVZ's -0.9%, ROIC 9.9% vs -2.3% |
BTX vs BLK vs STT vs BEN vs IVZ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BTX vs BLK vs STT vs BEN vs IVZ — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BTX leads in 1 of 6 categories
IVZ leads 1 • BLK leads 1 • STT leads 1 • BEN leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BTX leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
STT is the larger business by revenue, generating $22.0B annually — 540.0x BTX's $41M. BTX is the more profitable business, keeping 87.7% of every revenue dollar as net income compared to IVZ's -4.4%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $41M | $20.4B | $22.0B | $8.8B | $6.4B |
| EBITDAEarnings before interest/tax | — | $8.3B | $4.3B | $1.2B | $1.2B |
| Net IncomeAfter-tax profit | — | $6.1B | $3.0B | $812M | -$243M |
| Free Cash FlowCash after capex | — | $3.9B | -$6.1B | $938M | $1.9B |
| Gross MarginGross profit ÷ Revenue | +100.0% | +49.4% | +58.5% | +80.3% | +43.2% |
| Operating MarginEBIT ÷ Revenue | +87.7% | +37.1% | +15.5% | +6.9% | -10.9% |
| Net MarginNet income ÷ Revenue | +87.7% | +31.2% | +12.2% | +6.0% | -4.4% |
| FCF MarginFCF ÷ Revenue | +6.8% | +23.0% | -64.3% | +10.4% | +22.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | -22.7% | +23.0% | +100.0% | +34.2% |
Valuation Metrics
IVZ leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 18.1x trailing earnings, STT trades at a 62% valuation discount to BTX's 47.6x P/E. Adjusting for growth (PEG ratio), STT offers better value at 2.05x vs BLK's 3.13x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $945M | $165.7B | $42.0B | $15.9B | $11.9B |
| Enterprise ValueMkt cap + debt − cash | $945M | $167.1B | -$37.3B | $25.6B | $20.1B |
| Trailing P/EPrice ÷ TTM EPS | 47.65x | 25.42x | 18.12x | 33.54x | -16.77x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.10x | 11.99x | 11.21x | 10.44x |
| PEG RatioP/E ÷ EPS growth rate | — | 3.13x | 2.05x | — | — |
| EV / EBITDAEnterprise value multiple | 26.48x | 20.62x | -9.33x | 22.53x | 16.34x |
| Price / SalesMarket cap ÷ Revenue | 23.23x | 8.12x | 1.91x | 1.81x | 1.87x |
| Price / BookPrice ÷ Book value/share | 0.98x | 3.28x | 1.78x | 1.11x | 0.94x |
| Price / FCFMarket cap ÷ FCF | 3.41x | 35.24x | — | 17.40x | 8.27x |
Profitability & Efficiency
BLK leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
STT delivers a 10.8% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-2 for IVZ. BLK carries lower financial leverage with a 0.29x debt-to-equity ratio, signaling a more conservative balance sheet compared to STT's 1.45x. On the Piotroski fundamental quality scale (0–9), BLK scores 6/9 vs BTX's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.9% | +9.9% | +10.8% | +5.6% | -1.7% |
| ROA (TTM)Return on assets | +1.8% | +3.7% | +0.8% | +2.5% | -0.9% |
| ROICReturn on invested capital | +1.4% | +9.9% | +4.6% | +1.6% | -2.3% |
| ROCEReturn on capital employed | +1.8% | +5.8% | +4.6% | +2.0% | -2.6% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 4 | 6 | 6 |
| Debt / EquityFinancial leverage | — | 0.29x | 1.45x | 0.94x | 0.78x |
| Net DebtTotal debt minus cash | $0 | $1.5B | -$79.3B | $9.7B | $8.1B |
| Cash & Equiv.Liquid assets | — | $12.8B | $116.1B | $3.6B | $2.0B |
| Total DebtShort + long-term debt | $0 | $14.2B | $36.8B | $13.3B | $10.1B |
| Interest CoverageEBIT ÷ Interest expense | 2313.25x | 9.27x | 0.42x | 15.19x | -6.19x |
Total Returns (Dividends Reinvested)
STT leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in STT five years ago would be worth $18,620 today (with dividends reinvested), compared to $6,198 for BTX. Over the past 12 months, IVZ leads with a +93.1% total return vs BLK's +18.3%. The 3-year compound annual growth rate (CAGR) favors STT at 31.7% vs BEN's 10.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +24.2% | -1.1% | +16.6% | +29.6% | +0.4% |
| 1-Year ReturnPast 12 months | +37.7% | +18.3% | +66.2% | +55.5% | +93.1% |
| 3-Year ReturnCumulative with dividends | +43.5% | +75.7% | +128.4% | +35.3% | +79.8% |
| 5-Year ReturnCumulative with dividends | -38.0% | +33.5% | +86.2% | +7.4% | +8.2% |
| 10-Year ReturnCumulative with dividends | -37.6% | +245.8% | +186.8% | +23.5% | +22.1% |
| CAGR (3Y)Annualised 3-year return | +12.8% | +20.7% | +31.7% | +10.6% | +21.6% |
Risk & Volatility
Evenly matched — BTX and STT each lead in 1 of 2 comparable metrics.
Risk & Volatility
STT is the less volatile stock with a 1.19 beta — it tends to amplify market swings less than IVZ's 1.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BTX currently trades 98.5% from its 52-week high vs BLK's 87.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.29x | 1.28x | 1.19x | 1.31x | 1.67x |
| 52-Week HighHighest price in past year | $8.22 | $1219.94 | $156.18 | $31.44 | $29.61 |
| 52-Week LowLowest price in past year | $6.13 | $914.84 | $90.94 | $20.08 | $14.10 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +87.5% | +95.3% | +97.1% | +90.6% |
| RSI (14)Momentum oscillator 0–100 | 73.3 | 61.3 | 63.9 | 78.4 | 69.4 |
| Avg Volume (50D)Average daily shares traded | 727K | 790K | 2.0M | 5.1M | 5.1M |
Analyst Outlook
Evenly matched — BTX and BLK each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BLK as "Buy", STT as "Buy", BEN as "Hold", IVZ as "Hold". Consensus price targets imply 22.8% upside for BLK (target: $1312) vs -5.8% for BEN (target: $29). For income investors, BTX offers the higher dividend yield at 10.56% vs BLK's 1.92%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | — | $1311.78 | $160.44 | $28.75 | $29.72 |
| # AnalystsCovering analysts | — | 33 | 37 | 27 | 28 |
| Dividend YieldAnnual dividend ÷ price | +10.6% | +1.9% | +2.3% | +4.3% | +3.1% |
| Dividend StreakConsecutive years of raises | 1 | 15 | 3 | 6 | 4 |
| Dividend / ShareAnnual DPS | $0.86 | $20.46 | $3.42 | $1.33 | $0.83 |
| Buyback YieldShare repurchases ÷ mkt cap | +9.8% | +1.2% | +6.9% | +1.5% | +15.6% |
BTX leads in 1 of 6 categories (Income & Cash Flow). IVZ leads in 1 (Valuation Metrics). 2 tied.
BTX vs BLK vs STT vs BEN vs IVZ: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BTX or BLK or STT or BEN or IVZ a better buy right now?
For growth investors, State Street Corporation (STT) is the stronger pick with 19.
6% revenue growth year-over-year, versus -81. 1% for BlackRock Technology and Private Equity Term Trust (BTX). State Street Corporation (STT) offers the better valuation at 18. 1x trailing P/E (12. 0x forward), making it the more compelling value choice. Analysts rate BlackRock, Inc. (BLK) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BTX or BLK or STT or BEN or IVZ?
On trailing P/E, State Street Corporation (STT) is the cheapest at 18.
1x versus BlackRock Technology and Private Equity Term Trust at 47. 6x. On forward P/E, Invesco Ltd. is actually cheaper at 10. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: State Street Corporation wins at 1. 36x versus BlackRock, Inc. 's 2. 47x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — BTX or BLK or STT or BEN or IVZ?
Over the past 5 years, State Street Corporation (STT) delivered a total return of +86.
2%, compared to -38. 0% for BlackRock Technology and Private Equity Term Trust (BTX). Over 10 years, the gap is even starker: BLK returned +245. 8% versus BTX's -37. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BTX or BLK or STT or BEN or IVZ?
By beta (market sensitivity over 5 years), State Street Corporation (STT) is the lower-risk stock at 1.
19β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 41% more volatile than STT relative to the S&P 500. On balance sheet safety, BlackRock, Inc. (BLK) carries a lower debt/equity ratio of 29% versus 145% for State Street Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — BTX or BLK or STT or BEN or IVZ?
By revenue growth (latest reported year), State Street Corporation (STT) is pulling ahead at 19.
6% versus -81. 1% for BlackRock Technology and Private Equity Term Trust (BTX). On earnings-per-share growth, the picture is similar: State Street Corporation grew EPS 47. 1% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BTX or BLK or STT or BEN or IVZ?
BlackRock Technology and Private Equity Term Trust (BTX) is the more profitable company, earning 87.
7% net margin versus -4. 4% for Invesco Ltd. — meaning it keeps 87. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BTX leads at 87. 7% versus -10. 9% for IVZ. At the gross margin level — before operating expenses — BTX leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BTX or BLK or STT or BEN or IVZ more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, State Street Corporation (STT) is the more undervalued stock at a PEG of 1. 36x versus BlackRock, Inc. 's 2. 47x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Invesco Ltd. (IVZ) trades at 10. 4x forward P/E versus 20. 1x for BlackRock, Inc. — 9. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BLK: 22. 8% to $1311. 78.
08Which pays a better dividend — BTX or BLK or STT or BEN or IVZ?
All stocks in this comparison pay dividends.
BlackRock Technology and Private Equity Term Trust (BTX) offers the highest yield at 10. 6%, versus 1. 9% for BlackRock, Inc. (BLK).
09Is BTX or BLK or STT or BEN or IVZ better for a retirement portfolio?
For long-horizon retirement investors, State Street Corporation (STT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
19), 2. 3% yield, +186. 8% 10Y return). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (STT: +186. 8%, IVZ: +22. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BTX and BLK and STT and BEN and IVZ?
These companies operate in different sectors (BTX (Healthcare) and BLK (Financial Services) and STT (Financial Services) and BEN (Financial Services) and IVZ (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BTX is a small-cap income-oriented stock; BLK is a mid-cap quality compounder stock; STT is a mid-cap high-growth stock; BEN is a mid-cap income-oriented stock; IVZ is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.